ACARIX AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.321 SEK | -2.13% |
|
+5.42% | +69.13% |
| 06-11 | Acarix Announces Enrollment of First Patient in Us-Based Clinical Workflow Evaluation Study | CI |
| 05-27 | Acarix AB Appoints Jeff Thomas as the New Head of US Sales, Effective June 1, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Medical Diagnostic & Testing Equipment
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 30.3M | - | - | - | |||
| 16.26B | ||||||
| 2.44B | - | |||||
| 1.98B | - | - | ||||
| 1.52B | ||||||
| 1.3B |
- Stock Market
- Equities
- ACARIX Stock
- Charts Acarix AB
- Sector Chart